Literature DB >> 15740575

Further considerations on the distribution of multiple sclerosis in Sweden.

A-M Landtblom1, T Riise, J F Kurtzke.   

Abstract

OBJECTIVES: The geographic distribution of multiple sclerosis (MS) in Sweden over time was compared in order to analyze homogeneity.
METHODS: The distribution of MS was compared among three nationwide resources: 1301 hospital cases 1925-1934; 5425 deaths 1952-1992; and 11,371 disability pension recipients 1971-1994.
RESULTS: Distributions by county (lan) were markedly non-homogenous, with greatest variations in the early prevalence series (16-232% of the national mean), less within the death data (75-170%), and least for the disability series (87-128%). Maximal rates for MS in the early prevalence series were found for the cluster of seven counties surrounding the two major lakes of south central Sweden, as well as for one region on the northern shore of the Bay of Bothnia, and another also off the Bay north of Stockholm.
CONCLUSION: Though the epidemiologic sources are quite different, they are internally consistent and thus provide three consecutive cross-sectional views of the distribution over time. When considered together the data may be compatible with a thesis of the origin and spread of MS within Sweden from the south-central inland lake regions of the country. Such spread within a half century is too rapid for a genetic cause, including HLA patterns.

Entities:  

Mesh:

Year:  2005        PMID: 15740575     DOI: 10.1111/j.1600-0404.2005.00395.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  2 in total

1.  Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions.

Authors:  Kari Hemminki; Xinjun Li; Jan Sundquist; Jan Hillert; Kristina Sundquist
Journal:  Neurogenetics       Date:  2008-10-09       Impact factor: 2.660

2.  Multiple sclerosis in the far north--incidence and prevalence in Nordland County, Norway, 1970-2010.

Authors:  Espen Benjaminsen; Johnny Olavsen; Merethe Karlberg; Karl B Alstadhaug
Journal:  BMC Neurol       Date:  2014-12-04       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.